All stock lists
Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
Healthcare · Medical Devices
38.21+0.15 (+0.39%)
Insider Score
––Not scored
AXGN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AXGN analyst forecast
AXGN analyst consensus
Moderate Buy6 ratings
Buy 6 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
AXGN 12-month price target
$53.00+38.7% upsideaverage of 2 firms
$53.00High
$53.00Low
Best analysts covering AXGN
- Canaccord Genuity71%success rate · 7 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
AXGN analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Barclays | Overweight | — | — | Reiterated | 2026-10-23 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-10-01 |
| Truist Financial | — | $53.00 | +26.4% | — | 2026-10-01 | |
| Raymond James | Outperform | $53.00 | +22.3% | Reiterated | 2026-09-25 | |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-07-30 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-07-30 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-07-30 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-04-29 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-04-29 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-04-29 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-04-29 |
| — | Lake Street | Buy | — | — | Reiterated | 2026-04-23 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-03-30 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-02-24 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-12-05 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-12-05 |
| — | Jefferies | Buy | — | — | Reiterated | 2025-12-04 |
| — | Lake Street | Buy | — | — | Reiterated | 2025-12-04 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-10-30 |
| — | Raymond James | Outperform | — | — | Reiterated | 2025-10-30 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-10-30 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2025-10-30 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-05-13 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-03-05 |
| — | Citizens Capital Markets | Market Outperform | — | — | Reiterated | 2025-03-05 |
| — | Citizens Capital Markets | Market Outperform | — | — | Reiterated | 2025-02-26 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-02-26 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-02-03 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-08-09 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-06-20 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2024-01-19 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2023-12-07 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2023-09-26 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2023-08-22 |
| — | JMP Securities | Outperform | — | — | Reiterated | 2023-05-10 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2023-03-28 |
| — | JMP Securities | Outperform | — | — | Reiterated | 2023-03-15 |
| — | Canaccord Genuity | Buy | — | — | Upgraded | 2022-05-09 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2022-05-05 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2021-11-04 |
| — | Canaccord Genuity | Hold | — | — | Reiterated | 2021-05-06 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2021-02-23 |
| — | Canaccord Genuity | Hold | — | — | Reiterated | 2021-02-23 |
| — | Guggenheim | Buy | — | — | Reiterated | 2020-10-23 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2020-08-06 |
| — | Canaccord Genuity | Hold | — | — | Downgraded | 2020-05-07 |
| — | BTIG | Neutral | — | — | Downgraded | 2020-04-02 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2019-11-07 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2019-11-07 |
| — | William Blair | Market Perform | — | — | Downgraded | 2019-08-07 |
| — | BTIG | Buy | — | — | Upgraded | 2019-03-25 |
| — | BTIG Research | Buy | — | — | Upgraded | 2019-03-25 |
| — | BTIG Research | Neutral | — | — | Reiterated | 2018-11-14 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2018-10-30 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2018-05-01 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2018-05-01 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2018-03-01 |
| — | William Blair | Outperform | — | — | Reiterated | 2018-02-05 |
| — | Jefferies | Buy | — | — | Reiterated | 2017-11-30 |
| — | Leerink Swann | Outperform | — | — | Reiterated | 2017-11-21 |
AXGN earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-24 | 0.09 | 0.07 | $59.0M | $59.9M |
| 2026-04-28 | 0.12 | 0.07 | $57.8M | $61.5M |
| 2026-07-29 | 0.12 | 0.12 | $67.1M | $69.7M |
| 2026-10-28 | 0.13 | 0.00 | $73.2M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.